|
|
|
|
Vol. 10, Issue 9, 1393-1402, September 2000
LETTER
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
E. G. Grubbs, Z. Abdel-Wahab, D. S. Tyler, and S. K. Pruitt Utilizing Quantitative Polymerase Chain Reaction to Evaluate Prostate Stem Cell Antigen as a Tumor Marker in Pancreatic Cancer Ann. Surg. Oncol., December 1, 2006; 13(12): 1645 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Wang, Z. Zhang, H.-C. Wang, J.-L. Cai, Q.-W. Xu, M.-Q. Li, Y.-C. Chen, X.-P. Qian, T.-J. Lu, L.-Z. Yu, et al. Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder Carcinoma. Clin. Cancer Res., August 15, 2006; 12(16): 4851 - 4858. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Kuan, K. Wakiya, J. M. Dowell, J. E. Herndon II, D. A. Reardon, M. W. Graner, G. J. Riggins, C. J. Wikstrand, and D. D. Bigner Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin. Cancer Res., April 1, 2006; 12(7): 1970 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Tse, M. Jeffers, V. A. Pollack, D. A. McCabe, M. L. Shadish, N. V. Khramtsov, C. S. Hackett, S. G. Shenoy, B. Kuang, F. L. Boldog, et al. CR011, a Fully Human Monoclonal Antibody-Auristatin E Conjugate, for the Treatment of Melanoma Clin. Cancer Res., February 15, 2006; 12(4): 1373 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Graner and D. D. Bigner Chaperone proteins and brain tumors: Potential targets and possible therapeutics Neuro-oncol, July 1, 2005; 7(3): 260 - 278. [Abstract] [PDF] |
||||
![]() |
Q. Shi, S. Bao, J. A. Maxwell, E. D. Reese, H. S. Friedman, D. D. Bigner, X.-F. Wang, and J. N. Rich Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT Activation J. Biol. Chem., December 10, 2004; 279(50): 52200 - 52209. [Abstract] [Full Text] [PDF] |
||||
![]() |
I-M. Siu, A. Lal, J. R. Blankenship, N. Aldosari, and G. J. Riggins c-Myc Promoter Activation in Medulloblastoma Cancer Res., August 15, 2003; 63(16): 4773 - 4776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Rich, Q. Shi, M. Hjelmeland, T. J. Cummings, C.-T. Kuan, D. D. Bigner, C. M. Counter, and X.-F. Wang Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model J. Biol. Chem., April 25, 2003; 278(18): 15951 - 15957. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lal, H. Peters, B. St. Croix, Z. A. Haroon, M. W. Dewhirst, R. L. Strausberg, J. H. A. M. Kaanders, A. J. van der Kogel, and G. J. Riggins Transcriptional Response to Hypoxia in Human Tumors J Natl Cancer Inst, September 5, 2001; 93(17): 1337 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Polyak and G. J. Riggins Gene Discovery Using the Serial Analysis of Gene Expression Technique: Implications for Cancer Research J. Clin. Oncol., June 1, 2001; 19(11): 2948 - 2958. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Riggins and R. L. Strausberg Genome and genetic resources from the Cancer Genome Anatomy Project Hum. Mol. Genet., April 1, 2001; 10(7): 663 - 667. [Abstract] [Full Text] [PDF] |
||||